Oscar Health (OSCR) free cash flow

Free cash flow · fiscal 2025
$1.06B

Oscar Health (OSCR) generated free cash flow of $1.06B in fiscal 2025 (the year ended December 31, 2025). That is 11.4% higher than the $950.30M of fiscal 2024. Figures as of 18 Nov 2026, 12:41 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
$1.06B
Change on fiscal 2024
+11.4%
Growth, 5 years
+38.4% a year
Highest on record
$1.06Bfiscal 2025
Lowest on record
-$297.74Mfiscal 2023
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Oscar Health free cash flow, in more detail

Over the five fiscal years to 2025 free cash flow grew at a compound 38.4% a year. Across the 7 fiscal years on record (2019–2025), the highest was $1.06B in fiscal 2025 and the lowest -$297.74M in fiscal 2023.

History · 7 fiscal years

Free cash flow by fiscal year

Oscar Health free cash flow, year by year

Oscar Health (OSCR) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025$1.06B 11.4% up
2024$950.30M—
2023-$297.74M 184.7% down
2022$351.34M—
2021-$207.63M 199.5% down
2020$208.71M—
2019-$191.37M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of Oscar Health and comparable companies
CompanyFree cash flowFiscal year
Globus Medical GMED$579.02M2025
Madrigal Pharmaceuticals MDGL-$193.02M2025
Henry Schein HSIC$521.00M2025
Oscar Health OSCR$1.06B2025
TG Therapeutics TGTX-$24.99M2025
Praxis Precision Medicines PRAX-$249.12M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on OSCR

Oscar Health, figure by figure

Oscar Health (OSCR) overview: price, valuation and scorecardAll health care companies by market value

Oscar Health free cash flow: questions and answers

What is Oscar Health's free cash flow?

Oscar Health (OSCR) generated free cash flow of $1.06B in fiscal 2025 (the year ended December 31, 2025). That is 11.4% higher than the $950.30M of fiscal 2024.

What is the growth rate of Oscar Health's free cash flow?

Over the five fiscal years to 2025 free cash flow grew at a compound 38.4% a year.

What are the highest and lowest free cash flow figures on record for Oscar Health?

Across the 7 fiscal years on record (2019–2025), the highest was $1.06B in fiscal 2025 and the lowest -$297.74M in fiscal 2023.

How is Oscar Health's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Oscar Health it is on record here for 7 fiscal years, 2019 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Oscar Health (OSCR) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/OSCR/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.